MICHAELA BERNDT: Open Payments
NPI 1598315913 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $370 · 2025 $556
Food & beverage: $506Education: $50
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $133 |
| Genentech, Inc. | 1 | $123 |
| PharmaEssentia USA Corporation | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $50 |
| Iovance Biotherapeutics, Inc. | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Geron Corporation | 1 | $19 |
| GENZYME CORPORATION | 1 | $16 |
| Caris MPI, Inc. | 1 | $15 |
| Celgene Corporation | 1 | $15 |
Products named: RYBREVANT, BESREMI, Trodelvy, Amtagvi, Enhertu, RYTELO, SARCLISA, MI CANCER SEEK.
Industry payments across AR — which companies pay providers there.
